Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

Live donor liver transplantation for patients with hepatocellular carcinoma offers increased survival vs. deceased donation.

Goldaracena N, Gorgen A, Doyle A, Hansen BE, Tomiyama K, Zhang W, Ghanekar A, Lilly L, Cattral M, Galvin Z, Selzner M, Bhat M, Selzner N, McGilvray I, Greig PD, Grant DR, Sapisochin G.

J Hepatol. 2019 Jan 8. pii: S0168-8278(19)30003-0. doi: 10.1016/j.jhep.2018.12.029. [Epub ahead of print]

PMID:
30630009
2.

Outcomes of Radiofrequency Ablation as First-Line Therapy for Hepatocellular Carcinoma less than 3 cm in Potentially Transplantable Patients.

Doyle A, Gorgen A, Muaddi H, Aravinthan AD, Issachar A, Mironov O, Zhang W, Kachura J, Beecroft R, Cleary SP, Ghanekar A, Greig PD, McGilvray ID, Selzner M, Cattral MS, Grant DR, Lilly LB, Selzner N, Renner EL, Sherman M, Sapisochin G.

J Hepatol. 2019 Jan 4. pii: S0168-8278(19)30001-7. doi: 10.1016/j.jhep.2018.12.027. [Epub ahead of print]

PMID:
30615906
3.

Renal outcomes following left renal vein harvest for venous reconstruction during pancreas and liver surgery.

Loveday BPT, Dib MJ, Sequeira S, Alotaiby N, Visser R, Barbas AS, Wei AC, Cleary SP, Moulton CA, Gallinger S, Greig PD, McGilvray ID.

HPB (Oxford). 2019 Jan;21(1):114-120. doi: 10.1016/j.hpb.2018.07.015. Epub 2018 Oct 13.

PMID:
30322713
4.

Living Donor Liver Transplantation Using Selected Grafts With 2 Bile Ducts Compared With 1 Bile Duct Does Not Impact Patient Outcome.

Kollmann D, Goldaracena N, Sapisochin G, Linares I, Selzner N, Hansen BE, Bhat M, Cattral MS, Greig PD, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M.

Liver Transpl. 2018 Nov;24(11):1512-1522. doi: 10.1002/lt.25197.

PMID:
30264930
5.

Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrence.

Goldaracena N, Barbas AS, Galante A, Sapisochin G, Al-Adra D, Selzner N, Galvin Z, Cattral MS, Greig PD, Lilly L, Bhat M, McGilvray ID, Ghanekar A, Levy G, Grant DR, Selzner M.

Clin Transplant. 2018 Aug;32(8):e13304. doi: 10.1111/ctr.13304. Epub 2018 Jul 16.

PMID:
29947154
6.

Liver Transplantation Without Venovenous Bypass: Does Surgical Approach Matter?

Barbas AS, Levy J, Mulvihill MS, Goldaracena N, Dib MJ, Al-Adra DP, Cattral MS, Ghanekar A, Greig PD, Grant DR, Sapisochin G, Selzner M, McCluskey SA, McGilvray ID.

Transplant Direct. 2018 Apr 24;4(5):e348. doi: 10.1097/TXD.0000000000000776. eCollection 2018 May.

7.

Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation.

Kollmann D, Sapisochin G, Goldaracena N, Hansen BE, Rajakumar R, Selzner N, Bhat M, McCluskey S, Cattral MS, Greig PD, Lilly L, McGilvray ID, Ghanekar A, Grant DR, Selzner M.

Liver Transpl. 2018 Jun;24(6):779-789. doi: 10.1002/lt.25068. Epub 2018 May 14.

8.

Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada.

Loveday BPT, Knox JJ, Dawson LA, Metser U, Brade A, Horgan AM, Gallinger S, Greig PD, Moulton CA.

J Surg Oncol. 2018 Feb;117(2):213-219. doi: 10.1002/jso.24833.

PMID:
29480952
9.

Liver Transplantation is Equally Effective as a Salvage Therapy for Patients with Hepatocellular Carcinoma Recurrence Following Radiofrequency Ablation or Liver Resection with Curative Intent.

Muaddi H, Al-Adra DP, Beecroft R, Ghanekar A, Moulton CA, Doyle A, Selzner M, Wei A, McGilvray ID, Gallinger S, Grant DR, Cattral MS, Greig PD, Kachura J, Cleary SP, Sapisochin G.

Ann Surg Oncol. 2018 Apr;25(4):991-999. doi: 10.1245/s10434-017-6329-x. Epub 2018 Jan 11.

PMID:
29327179
10.

Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma.

Sadler EM, Mehta N, Bhat M, Ghanekar A, Greig PD, Grant DR, Yao F, Sapisochin G.

Transplantation. 2018 Apr;102(4):640-647. doi: 10.1097/TP.0000000000002043.

PMID:
29319620
11.

Avoiding ICU Admission by Using a Fast-Track Protocol Is Safe in Selected Adult-to-Adult Live Donor Liver Transplant Recipients.

Echeverri J, Goldaracena N, Singh AK, Sapisochin G, Selzner N, Cattral MS, Greig PD, Lilly L, McGilvray ID, Levy GA, Ghanekar A, Renner EL, Grant DR, McCluskey SA, Selzner M.

Transplant Direct. 2017 Sep 18;3(10):e213. doi: 10.1097/TXD.0000000000000730. eCollection 2017 Oct.

12.

Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results.

Muller X, Marcon F, Sapisochin G, Marquez M, Dondero F, Rayar M, Doyle MMB, Callans L, Li J, Nowak G, Allard MA, Jochmans I, Jacskon K, Beltrame MC, van Reeven M, Iesari S, Cucchetti A, Sharma H, Staiger RD, Raptis DA, Petrowsky H, de Oliveira M, Hernandez-Alejandro R, Pinna AD, Lerut J, Polak WG, de Santibañes E, de Santibañes M, Cameron AM, Pirenne J, Cherqui D, Adam RA, Ericzon BG, Nashan B, Olthoff K, Shaked A, Chapman WC, Boudjema K, Soubrane O, Paugam-Burtz C, Greig PD, Grant DR, Carvalheiro A, Muiesan P, Dutkowski P, Puhan M, Clavien PA.

Ann Surg. 2018 Mar;267(3):419-425. doi: 10.1097/SLA.0000000000002477.

13.

Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control study.

Aravinthan AD, Barbas AS, Doyle AC, Tazari M, Sapisochin G, Cattral MS, Ghanekar A, McGilvray ID, Selzner M, Greig PD, Bhat M, Selzner N, Grant DR, Lilly LB, Renner EL.

Transpl Int. 2017 Nov;30(11):1140-1149. doi: 10.1111/tri.13008. Epub 2017 Jul 27.

14.

Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience.

Barbas AS, Goldaracena N, Dib MJ, Al-Adra DP, Aravinthan AD, Lilly LB, Renner EL, Selzner N, Bhat M, Cattral MS, Ghanekar A, McGilvray ID, Sapisochin G, Selzner M, Greig PD, Grant DR.

Transplant Direct. 2017 May 10;3(6):e158. doi: 10.1097/TXD.0000000000000674. eCollection 2017 Jun.

15.

In memoriam of Dr. Tom Starzl.

Greig PD.

Can J Surg. 2017 Jun;60(3):E1. No abstract available.

16.

Visualising a rare and complex case of advanced hilar cholangiocarcinoma.

Qu J, Fung A, Kelly P, Tait G, Greig PD, Agur A, McGilvray ID, Jenkinson J.

J Vis Commun Med. 2017 Jan;40(1):26-31. doi: 10.1080/17453054.2017.1289060. Epub 2017 Mar 14.

PMID:
28290711
17.

Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis.

Sapisochin G, Barry A, Doherty M, Fischer S, Goldaracena N, Rosales R, Russo M, Beecroft R, Ghanekar A, Bhat M, Brierley J, Greig PD, Knox JJ, Dawson LA, Grant DR.

J Hepatol. 2017 Jul;67(1):92-99. doi: 10.1016/j.jhep.2017.02.022. Epub 2017 Feb 28.

PMID:
28257902
18.

Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.

Serrano PE, Kim D, Kim PT, Greig PD, Moulton CA, Gallinger S, Wei AC, Cleary SP.

Am Surg. 2016 Dec 1;82(12):1187-1195.

PMID:
28234183
19.

Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular Carcinoma.

Aravinthan AD, Bruni SG, Doyle AC, Thein HH, Goldaracena N, Issachar A, Lilly LB, Selzner N, Bhat M, Sreeharsha B, Selzner M, Ghanekar A, Cattral MS, McGilvray ID, Greig PD, Renner EL, Grant DR, Sapisochin G.

Ann Surg Oncol. 2017 Jul;24(7):1843-1851. doi: 10.1245/s10434-017-5789-3. Epub 2017 Feb 3.

PMID:
28160137
20.

The influence of fellowship training on the practice of pancreatoduodenectomy.

Kennedy GT, McMillan MT, Sprys MH, Bassi C, Greig PD, Hansen PD, Jeyarajah DR, Kent TS, Malleo G, Marchegiani G, Minter RM, Vollmer CM Jr.

HPB (Oxford). 2016 Dec;18(12):965-978. doi: 10.1016/j.hpb.2016.09.008. Epub 2016 Oct 28.

21.

Hepatocellular Carcinoma: The Role of Interventional Oncology.

Donadon M, Solbiati L, Dawson L, Barry A, Sapisochin G, Greig PD, Shiina S, Fontana A, Torzilli G.

Liver Cancer. 2016 Nov;6(1):34-43. Epub 2016 Nov 29. Review.

22.

Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.

Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, Burns JM, Sanchez W, Greig PD, Grant DR, Roberts JP, Yao FY.

JAMA Oncol. 2017 Apr 1;3(4):493-500. doi: 10.1001/jamaoncol.2016.5116.

23.

Normothermic ex vivo liver perfusion using steen solution as perfusate for human liver transplantation: First North American results.

Selzner M, Goldaracena N, Echeverri J, Kaths JM, Linares I, Selzner N, Serrick C, Marquez M, Sapisochin G, Renner EL, Bhat M, McGilvray ID, Lilly L, Greig PD, Tsien C, Cattral MS, Ghanekar A, Grant DR.

Liver Transpl. 2016 Nov;22(11):1501-1508. doi: 10.1002/lt.24499.

24.

Donor BMI >30 Is Not a Contraindication for Live Liver Donation.

Knaak M, Goldaracena N, Doyle A, Cattral MS, Greig PD, Lilly L, McGilvray ID, Levy GA, Ghanekar A, Renner EL, Grant DR, Selzner M, Selzner N.

Am J Transplant. 2017 Mar;17(3):754-760. doi: 10.1111/ajt.14019. Epub 2016 Sep 19.

25.

Should We Exclude Live Donor Liver Transplantation for Liver Transplant Recipients Requiring Mechanical Ventilation and Intensive Care Unit Care?

Goldaracena N, Spetzler VN, Sapisochin G, J E, Moritz K, Cattral MS, Greig PD, Lilly L, McGilvray ID, Levy GA, Ghanekar A, Renner EL, Grant DR, Selzner M, Selzner N.

Transplant Direct. 2015 Sep 22;1(8):e30. doi: 10.1097/TXD.0000000000000543. eCollection 2015 Sep.

26.

Defining Benchmarks for Major Liver Surgery: A multicenter Analysis of 5202 Living Liver Donors.

Rössler F, Sapisochin G, Song G, Lin YH, Simpson MA, Hasegawa K, Laurenzi A, Sánchez Cabús S, Nunez MI, Gatti A, Beltrame MC, Slankamenac K, Greig PD, Lee SG, Chen CL, Grant DR, Pomfret EA, Kokudo N, Cherqui D, Olthoff KM, Shaked A, García-Valdecasas JC, Lerut J, Troisi RI, De Santibanes M, Petrowsky H, Puhan MA, Clavien PA.

Ann Surg. 2016 Sep;264(3):492-500. doi: 10.1097/SLA.0000000000001849.

27.

Creating an animation-enhanced video library of hepato-pancreato-biliary and transplantation surgical procedures.

Fung A, Kelly P, Tait G, Greig PD, McGilvray ID.

J Vis Commun Med. 2016 Jan-Jun;39(1-2):27-32. doi: 10.1080/17453054.2016.1182474. Epub 2016 Jun 3.

PMID:
27261244
28.

The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.

Sapisochin G, Goldaracena N, Laurence JM, Dib M, Barbas A, Ghanekar A, Cleary SP, Lilly L, Cattral MS, Marquez M, Selzner M, Renner E, Selzner N, McGilvray ID, Greig PD, Grant DR.

Hepatology. 2016 Dec;64(6):2077-2088. doi: 10.1002/hep.28643. Epub 2016 Jun 30.

PMID:
27178646
29.

Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional Evaluation.

Leal JN, Bressan AK, Vachharajani N, Gonen M, Kingham TP, D'Angelica MI, Allen PJ, DeMatteo RP, Doyle MB, Bathe OF, Greig PD, Wei A, Chapman WC, Dixon E, Jarnagin WR.

J Am Coll Surg. 2016 May;222(5):766-79. doi: 10.1016/j.jamcollsurg.2016.01.046. Epub 2016 Jan 30.

30.

First-Degree Living-Related Donor Liver Transplantation in Autoimmune Liver Diseases.

Aravinthan AD, Doyle AC, Issachar A, Dib M, Peretz D, Cattral MS, Ghanekar A, McGilvray ID, Selzner M, Greig PD, Grant DR, Selzner N, Lilly LB, Renner EL.

Am J Transplant. 2016 Dec;16(12):3512-3521. doi: 10.1111/ajt.13828. Epub 2016 May 23.

31.

High preoperative bilirubin values protect against reperfusion injury after live donor liver transplantation.

Spetzler VN, Goldaracena N, Kaths JM, Marquez M, Selzner N, Cattral MS, Greig PD, Lilly L, McGilvray ID, Levy GA, Ghanekar A, Renner EL, Grant DR, Selzner M.

Transpl Int. 2015 Nov;28(11):1317-25. doi: 10.1111/tri.12634. Epub 2015 Jul 23.

32.

Live Donor Liver Transplantation With Older (≥50 Years) Versus Younger (<50 Years) Donors: Does Age Matter?

Goldaracena N, Sapisochin G, Spetzler V, Echeverri J, Kaths M, Cattral MS, Greig PD, Lilly L, McGilvray ID, Levy GA, Ghanekar A, Renner EL, Grant DR, Selzner M, Selzner N.

Ann Surg. 2016 May;263(5):979-85. doi: 10.1097/SLA.0000000000001337.

PMID:
26106842
33.

Live donor liver transplantation: a valid alternative for critically ill patients suffering from acute liver failure.

Goldaracena N, Spetzler VN, Marquez M, Selzner N, Cattral MS, Greig PD, Lilly L, McGilvray ID, Levy GA, Ghanekar A, Renner EL, Grant DR, Selzner M.

Am J Transplant. 2015 Jun;15(6):1591-7. doi: 10.1111/ajt.13203. Epub 2015 Mar 19.

34.

Dr. Bernard Langer - inductee into the Canadian Medical Hall of Fame.

Greig PD, Rotstein OD.

Can J Surg. 2015 Apr;58(2):80-2.

35.

Training in Hepatopancreatobiliary Surgery: Assessment of the Hepatopancreatobiliary Surgery Workforce in North America.

Minter RM, Alseidi A, Hong JC, Jeyarajah DR, Greig PD, Dixon E, Thumma JR, Pawlik TM.

Ann Surg. 2015 Dec;262(6):1065-70. doi: 10.1097/SLA.0000000000001096.

PMID:
25751311
36.

Long-term follow-up of biliary complications after adult right-lobe living donor liver transplantation.

Kim PT, Marquez M, Jung J, Cavallucci D, Renner EL, Cattral M, Greig PD, McGilvray ID, Selzner M, Ghanekar A, Grant DR.

Clin Transplant. 2015 May;29(5):465-74. doi: 10.1111/ctr.12538. Epub 2015 Apr 10.

PMID:
25740227
37.

The effect of recipient age on outcome after pancreas transplantation.

Laurence JM, Marquez MA, Seal JB, Sapisochin G, Bazerbachi F, Selzner M, Norgate A, Greig PD, McGilvray ID, Schiff J, Cattral MS.

Transplantation. 2015 Feb;99(2):e13-4. doi: 10.1097/TP.0000000000000554. No abstract available.

PMID:
25651123
38.

Duodenal leaks after pancreas transplantation with enteric drainage - characteristics and risk factors.

Spetzler VN, Goldaracena N, Marquez MA, Singh SK, Norgate A, McGilvray ID, Schiff J, Greig PD, Cattral MS, Selzner M.

Transpl Int. 2015 Jun;28(6):720-8. doi: 10.1111/tri.12535. Epub 2015 Feb 23.

39.

Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.

Sapisochin G, Goldaracena N, Astete S, Laurence JM, Davidson D, Rafael E, Castells L, Sandroussi C, Bilbao I, Dopazo C, Grant DR, Lázaro JL, Caralt M, Ghanekar A, McGilvray ID, Lilly L, Cattral MS, Selzner M, Charco R, Greig PD.

Ann Surg Oncol. 2015 Jul;22(7):2286-94. doi: 10.1245/s10434-014-4273-6. Epub 2014 Dec 4.

PMID:
25472651
40.

Risk factors associated with recurrence in patients with solid pseudopapillary tumors of the pancreas.

Serrano PE, Serra S, Al-Ali H, Gallinger S, Greig PD, McGilvray ID, Moulton CA, Wei AC, Cleary SP.

JOP. 2014 Nov 28;15(6):561-8. doi: 10.6092/1590-8577/2423.

41.

Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.

Serrano PE, Cleary SP, Dhani N, Kim PT, Greig PD, Leung K, Moulton CA, Gallinger S, Wei AC.

Ann Surg Oncol. 2015 Apr;22(4):1160-7. doi: 10.1245/s10434-014-4196-2. Epub 2014 Oct 28.

PMID:
25348784
42.

Laparoscopic versus open liver resection for hepatocellular carcinoma at a North-American Centre: a 2-to-1 matched pair analysis.

Lee JJ, Conneely JB, Smoot RL, Gallinger S, Greig PD, Moulton CA, Wei A, McGilvray I, Cleary SP.

HPB (Oxford). 2015 Apr;17(4):304-10. doi: 10.1111/hpb.12342. Epub 2014 Oct 9.

43.

Living vs. deceased donor liver transplantation provides comparable recovery of renal function in patients with hepatorenal syndrome: a matched case-control study.

Goldaracena N, Marquez M, Selzner N, Spetzler VN, Cattral MS, Greig PD, Lilly L, McGilvray ID, Levy GA, Ghanekar A, Renner EL, Grant DR, Selzner M.

Am J Transplant. 2014 Dec;14(12):2788-95. doi: 10.1111/ajt.12975. Epub 2014 Oct 2.

44.

Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.

Lee JJ, Kim PT, Fischer S, Fung S, Gallinger S, McGilvray I, Moulton CA, Wei AC, Greig PD, Cleary SP.

Ann Surg Oncol. 2014 Aug;21(8):2708-16. doi: 10.1245/s10434-014-3609-6. Epub 2014 May 8.

PMID:
24806113
45.

Frequency and significance of IgG4 immunohistochemical staining in liver explants from patients with primary sclerosing cholangitis.

Fischer S, Trivedi PJ, Ward S, Greig PD, Therapondos G, Hirschfield GM.

Int J Exp Pathol. 2014 Jun;95(3):209-15. doi: 10.1111/iep.12076. Epub 2014 Apr 18.

46.

Combined pancreaticoduodenectomy and colon resection for locally advanced peri-ampullary tumours: analysis of peri-operative morbidity and mortality.

Temple SJ, Kim PT, Serrano PE, Kagedan D, Cleary SP, Moulton CA, McGilvray ID, Gallinger S, Greig PD, Wei AC.

HPB (Oxford). 2014 Sep;16(9):797-800. doi: 10.1111/hpb.12263. Epub 2014 Apr 18.

47.

Mesocaval shunting.

Conneely JB, Smoot RL, Greig PD, McGilvray ID.

J Am Coll Surg. 2014 Feb;218(2):306-7. doi: 10.1016/j.jamcollsurg.2013.10.007. No abstract available.

PMID:
24440073
48.

Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.

Morin E, Cheng S, Mete O, Serra S, Araujo PB, Temple S, Cleary S, Gallinger S, Greig PD, McGilvray I, Wei A, Asa SL, Ezzat S.

Cancer Med. 2013 Oct;2(5):701-11. doi: 10.1002/cam4.96. Epub 2013 Aug 6.

49.

Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma.

Kim PT, Jang JH, Atenafu EG, Fischer S, Greig PD, McGilvray ID, Wei AC, Gallinger S, Cleary SP.

Br J Surg. 2013 Oct;100(11):1516-22. doi: 10.1002/bjs.9263.

PMID:
24037575
50.

Planned versus unplanned portal vein resections during pancreaticoduodenectomy for adenocarcinoma.

Kim PT, Wei AC, Atenafu EG, Cavallucci D, Cleary SP, Moulton CA, Greig PD, Gallinger S, Serra S, McGilvray ID.

Br J Surg. 2013 Sep;100(10):1349-56. doi: 10.1002/bjs.9222.

PMID:
23939847

Supplemental Content

Loading ...
Support Center